Reinventing with generative AI: How the Life Sciences industry is leading the way

Generative AI has become an extraordinary force in enabling reinvention. Hear how generative AI is being used to help accelerate the development of drugs, redesign clinical trials and hyper-personalize interactions between pharma companies and patients, and with healthcare professionals. Jack Azagury, Group Chief Executive - Strategy & Consulting and Dr. Petra Jantzer - Life Sciences Lead, discuss our latest Accenture research: Reinvention in the age of generative AI.
To read the report, visit: https://accntu.re/3I13ii5

Watch the complete interview – exclusively available on our Foresight App: https://accntu.re/3I3LKld

#generativeAI #genAI #lifesciences

Видео Reinventing with generative AI: How the Life Sciences industry is leading the way канала Accenture